Phung N Thai1, Lu Ren1, Wilson Xu1, James Overton1, Valeriy Timofeyev1, Carol E Nader1, Michael Haddad1, Jun Yang2, Aldrin V Gomes3, Bruce D Hammock2, Nipavan Chiamvimonvat4,5,6, Padmini Sirish7,8. 1. Department of Internal Medicine, Division of Cardiovascular Medicine, University of California, Davis, 451 Health Science Drive, CA, 95616, Davis, USA. 2. Department of Entomology and Nematology and Comprehensive Cancer Center, University of California, Davis, CA, USA. 3. Department of Physiology and Membrane Biology, University of California, Davis, CA, USA. 4. Department of Internal Medicine, Division of Cardiovascular Medicine, University of California, Davis, 451 Health Science Drive, CA, 95616, Davis, USA. nchiamvimonvat@ucdavis.edu. 5. Department of Pharmacology, University of California, Davis, CA, USA. nchiamvimonvat@ucdavis.edu. 6. Department of Veterans Affairs, Northern California Health Care System, 10535 Hospital Way, Mather, CA, 95655, USA. nchiamvimonvat@ucdavis.edu. 7. Department of Internal Medicine, Division of Cardiovascular Medicine, University of California, Davis, 451 Health Science Drive, CA, 95616, Davis, USA. psirish@ucdavis.edu. 8. Department of Veterans Affairs, Northern California Health Care System, 10535 Hospital Way, Mather, CA, 95655, USA. psirish@ucdavis.edu.
Abstract
PURPOSE: Nonsteroidal anti-inflammatory drugs (NSAIDs) are among one of the most commonly prescribed medications for pain and inflammation. Diclofenac (DIC) is a commonly prescribed NSAID that is known to increase the risk of cardiovascular diseases. However, the mechanisms underlying its cardiotoxic effects remain largely unknown. In this study, we tested the hypothesis that chronic exposure to DIC increases oxidative stress, which ultimately impairs cardiovascular function. METHODS AND RESULTS: Mice were treated with DIC for 4 weeks and subsequently subjected to in vivo and in vitro functional assessments. Chronic DIC exposure resulted in not only systolic but also diastolic dysfunction. DIC treatment, however, did not alter blood pressure or electrocardiographic recordings. Importantly, treatment with DIC significantly increased inflammatory cytokines and chemokines as well as cardiac fibroblast activation and proliferation. There was increased reactive oxygen species (ROS) production in cardiomyocytes from DIC-treated mice, which may contribute to the more depolarized mitochondrial membrane potential and reduced energy production, leading to a significant decrease in sarcoplasmic reticulum (SR) Ca2+ load, Ca2+ transients, and sarcomere shortening. Using unbiased metabolomic analyses, we demonstrated significant alterations in oxylipin profiles towards inflammatory features in chronic DIC treatment. CONCLUSIONS: Together, chronic treatment with DIC resulted in severe cardiotoxicity, which was mediated, in part, by an increase in mitochondrial oxidative stress.
PURPOSE: Nonsteroidal anti-inflammatory drugs (NSAIDs) are among one of the most commonly prescribed medications for pain and inflammation. Diclofenac (DIC) is a commonly prescribed NSAID that is known to increase the risk of cardiovascular diseases. However, the mechanisms underlying its cardiotoxic effects remain largely unknown. In this study, we tested the hypothesis that chronic exposure to DIC increases oxidative stress, which ultimately impairs cardiovascular function. METHODS AND RESULTS: Mice were treated with DIC for 4 weeks and subsequently subjected to in vivo and in vitro functional assessments. Chronic DIC exposure resulted in not only systolic but also diastolic dysfunction. DIC treatment, however, did not alter blood pressure or electrocardiographic recordings. Importantly, treatment with DIC significantly increased inflammatory cytokines and chemokines as well as cardiac fibroblast activation and proliferation. There was increased reactive oxygen species (ROS) production in cardiomyocytes from DIC-treated mice, which may contribute to the more depolarized mitochondrial membrane potential and reduced energy production, leading to a significant decrease in sarcoplasmic reticulum (SR) Ca2+ load, Ca2+ transients, and sarcomere shortening. Using unbiased metabolomic analyses, we demonstrated significant alterations in oxylipin profiles towards inflammatory features in chronic DIC treatment. CONCLUSIONS: Together, chronic treatment with DIC resulted in severe cardiotoxicity, which was mediated, in part, by an increase in mitochondrial oxidative stress.
Authors: Sumanta Kumar Goswami; Amelia Ann Rand; Debin Wan; Jun Yang; Bora Inceoglu; Melany Thomas; Christophe Morisseau; Guang-Yu Yang; Bruce D Hammock Journal: Life Sci Date: 2017-05-15 Impact factor: 5.037
Authors: David M Roth; James S Swaney; Nancy D Dalton; Elizabeth A Gilpin; John Ross Journal: Am J Physiol Heart Circ Physiol Date: 2002-06 Impact factor: 4.733
Authors: Dao-Fu Dai; Simon C Johnson; Jason J Villarin; Michael T Chin; Madeline Nieves-Cintrón; Tony Chen; David J Marcinek; Gerald W Dorn; Y James Kang; Tomas A Prolla; Luis F Santana; Peter S Rabinovitch Journal: Circ Res Date: 2011-02-10 Impact factor: 17.367
Authors: Manja M Krause; Martin D Brand; Stefan Krauss; Christian Meisel; Hartmut Vergin; Gerd-Rüdiger Burmester; Frank Buttgereit Journal: Arthritis Rheum Date: 2003-05